Cassling

JANUARY 9, 2025

EchoSolv, the groundbreaking AI platform developed by Echo IQ, is revolutionizing the detection of aortic stenosis. With its unparalleled access to extensive echocardiographic data and AI-driven analysis, EchoSolv empowers clinicians to identify aortic stenosis earlier and with greater accuracy. In this video, Prof.

Heart Disease 52

Heart Disease Stenosis Aortic Innovation 52

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. A treatment for patients with aortic valve disease is surgical aortic valve replacement (SAVR).

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. JenaValve presented positive results of its U.S.

Innovation 105

Innovation Aortic valve Aortic CMS 105

Frontiers in Cardiovascular Medicine

JUNE 3, 2024

Abdominal aortic aneurysm (AAA) is a significant source of mortality worldwide and carries a mortality of greater than 80% after rupture. Despite extensive efforts to develop pharmacological treatments, there is currently no effective agent to prevent aneurysm growth and rupture.

Aneurysm 69

Aneurysm Aortic Pharmacology Innovation 69

DAIC

FEBRUARY 22, 2024

Photo courtesy of Mount Sinai Health System milla1cf Thu, 02/22/2024 - 13:47 February 22, 2024 — Ismail El-Hamamsy , MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B. The aortic valve controls blood flow from the heart into the aorta, the main artery that feeds blood to most of the body.

Heart Valves 142

Heart Valves Aortic valve Aortic Sudden Cardiac Death 142

Journal of Cardiothoracic Surgery

AUGUST 29, 2024

Background Aortic regurgitation with dilated annulus presents a technical challenge for conventional transcatheter aortic valve implantation (TAVI) procedures. The patient underwent a successful TAVI procedure using the XL-Myval 32 mm transcatheter heart valve (THV) via an anterior right mini-thoracotomy with a direct aortic approach.

Aortic 52

Aortic Aortic valve Heart Valves Innovation 52

DAIC

MARCH 25, 2024

Fethi Benraouane , and Dr. Molham Aldeiri , have successfully performed the first series of transcarotid Transcatheter Aortic Valve Replacement (TAVR) procedures ever done in Southeast Houston. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients.

TAVR 111

TAVR Open-Heart Surgery Aortic valve Aortic 111

CTVS

JULY 25, 2023

It’s been more than five years since CTVS was the first practice in Central Texas to pioneer use of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in a pivotal research study for treating aortic disease.

Aortic 52

Aortic Innovation Cardiothoracic Research 52

DAIC

MAY 1, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

Frontiers in Cardiovascular Medicine

MAY 8, 2024

In high-risk patients with pure native aortic regurgitation (PNAR), transcatheter aortic valve replacement (TAVR) remains an off-label intervention. In this context, we successfully and safely performed a snare-assisted TF-TAVR procedure for a patient with PNAR, characterized by significant aortic angulation.

Aortic 52

Aortic TAVR Aortic valve Innovation 52

DAIC

JANUARY 4, 2024

In all cases, patients achieved complete resolution of aortic disease with no residual stenosis or regurgitation immediately following the procedure, and all patients were discharged within 24-48 hours of the procedure.

Aortic valve 105

Aortic valve Heart Valves Aortic Technology 105

DAIC

JANUARY 31, 2024

FDA approval of this innovation builds on a proven device which has become an important tool for treating complex vascular disease. market over the coming months and is also being studied in the Type IV Thoracoabdominal Aortic Aneurysms (TAMBE) Trial ( NCT02528500 ). "The Gore & Associates, Inc. Currently in the U.S.,

Stents 111

Stents Stent Innovation Aortic 111

DAIC

FEBRUARY 3, 2025

Roche has an unrivaled ability to provide access to testing at scale and is committed to advancing innovation in preventive cardiology. More than 90% of the Lp(a) level is influenced by variations in the genes controlling the Lp(a) particle production, 2 in which lifestyle interventions such as diet and exercise have no significant impact.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

The British Journal of Cardiology

AUGUST 6, 2024

It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials. In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment.

Innovation 53

Innovation Heart Valves Heart Disease Article 53

DAIC

JANUARY 5, 2024

Joint Statement on Aortic Valve Replacement in Low-Risk Patients Issued by Society of Thoracic Surgeons and European Association for Cardiothoracic Surgeons 6. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study Atrial Fibrillation Market Reaches $20.92B, According to New Report 9.

Atrial Fibrillation 105

Atrial Fibrillation Aortic valve Cardiothoracic Interventional Cardiology 105

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR 111

TAVR Aortic valve Aortic Stenosis 111

DAIC

APRIL 5, 2024

This is a leading event in the cardiovascular medicine calendar, which brings together specialists from around the world to discuss the latest advances, research results and clinical innovations in the field of cardiology. A summary of the poster session will be published on the Journal of the American College of Cardiology’s website.

Aortic valve 52

Aortic valve Stenosis Aortic Quality of Life 52

DAIC

DECEMBER 26, 2023

reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc. the R&D Manager of MindMics.

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

DAIC

APRIL 1, 2024

“The concepts I wrote in this paper also form the crux of what we are doing here at the Center for Innovation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

Journal of the American Heart Association

APRIL 30, 2024

Journal of the American Heart Association, Ahead of Print.

Innovation 45

Innovation Aortic 45

Dr. S. Venkatesan MD

APRIL 10, 2024

A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. The investigations revealed a stuck aortic prosthetic valve ,that showed a prohibitive gradient of more than 50 mmhg.

Aortic valve 52

Aortic valve Aortic Thrombosis Bicuspid/Mitral 52

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

JANUARY 22, 2024

These are true innovators who propose novel approaches to major research challenges in the areas of heart disease, stroke and brain health. Blood lipids such as cholesterol and triglycerides are causal risk factors for coronary heart disease as well as several other types of cardiovascular disease , such as aortic stenosis).

Heart Disease 105

Heart Disease Research Aneurysm Cardiovascular Disease 105

The New England Journal of Medicine

OCTOBER 29, 2024

The past two decades have witnessed a renaissance in the evaluation and treatment of patients with valvular heart disease, catalyzed by advances in surgical innovation, transcatheter techniques, and multimodality cardiac imaging.

Aortic valve 40

Aortic valve Tricuspid TAVR Aortic 40

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Society of Thoracic Surgeons - Allied Health

JUNE 22, 2023

The program directors have chosen an ambitious theme of "The Taming of the Aortic Valves," inspired by Shakespeare's classic The Taming of the Shrew. Trainees, residents, and practicing physicians will train on surgical techniques via wet labs, and hear the latest on TAVI, innovative SAVR, and endocarditis.

Heart Valves 52

Heart Valves Aortic valve Allied Health Cardiovascular Surgery 52

Stroke Journal

FEBRUARY 1, 2024

Background:Carotid endarterectomy (CEA) and debranching thoracic endovascular aortic repair (debranching TEVAR) would lead to the reduction of cerebral blood flow (CBF) during carotid artery clamping. Intravenous anesthetics decrease CBF more than volatile anesthetics and may exacerbate cerebral hypoperfusion during carotid artery clamping.

Aortic 40

Aortic Innovation Stroke Strokes 40

Journal of the American Heart Association

MARCH 5, 2025

We observed upregulation of USP29 protein levels in both transverse aortic constrictioninduced hypertrophic hearts (upregulated by 159.8%) and phenylephrineinduced hypertrophic cardiomyocytes (upregulated by 184.6%). ConclusionsHere, we have identified USP29 as a novel negative regulator of pathological cardiac hypertrophy.

Heart Failure 45

Heart Failure Aortic Innovation 45

DAIC

FEBRUARY 9, 2024

Photo by Cedars-Sinai Raj Makkar, MD , associate director of the Smidt Heart Institute and vice president of Cardiovascular Innovation and Intervention for Cedars-Sinai, was the principal investigator for the TRISCEND II trial at Cedars-Sinai. Raj Makkar, MD. Corday, MD, Chair in Interventional Cardiology. “It

Tricuspid 105

Tricuspid Open-Heart Surgery Interventional Cardiology Bicuspid/Mitral 105

DAIC

JUNE 27, 2024

Additionally, the exhibit hall will provide an opportunity to discuss the latest cardiac CT technology innovations with vendors, while discussions in the poster area ofer a deep dive into current studies and applications of the latest products. AMA PRA Category 1 Credits; in addition, SCCT24 program planners note that 13.75

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

ADN Center of Excellence

DECEMBER 14, 2023

At ADN CoE, we are dedicated to empowering medical professionals through a diverse range of fellowship programs meticulously crafted to nurture expertise and innovation. This testimonial exemplifies the commitment to excellence and innovation that defines our fellowship programs.

Innovation 52

Innovation Heart Valves Aortic valve Cardiovascular Surgery 52

Wellnest

JANUARY 24, 2024

This innovative technique not only provides functional heart valves for neonates but also offers the promise of lifelong solutions, transforming the landscape of pediatric heart surgeries. The donor’s aortic root was transplanted first, leveraging donor tissue to close the ventricular septal defect.

Heart Transplant 52

Heart Transplant Transplant Pediatrics Congenital 52

Society of Thoracic Surgeons - Early Career

NOVEMBER 19, 2024

Learn how to know when it's appropriate to break the rules, when to challenge your superiors, how to do so without endangering your career and how to foster learning and innovation among the ranks of people conditioned to follow orders.

Cardiothoracic 52

Cardiothoracic Blog Webinar Aortic valve 52

DAIC

JULY 29, 2024

Magenta's technology stands at the forefront of innovation in the MCS field and has the potential to significantly improve outcomes in patients with severe cardiovascular conditions,” said Eric Snyder, Partner, Venture Investments, Novo Holdings US. The financing will be used to advance the company’s U.S.

Cardiogenic Shock 105

Cardiogenic Shock Blood Pressure Technology Aortic valve 105

ADN Center of Excellence

JANUARY 14, 2024

Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass. Spearheaded by the eminent Prof. Under the guidance of Prof.

Interventional Cardiology 59

Interventional Cardiology Education Heart Valves Aortic valve 59